Mark Hull

4.1k total citations
141 papers, 2.2k citations indexed

About

Mark Hull is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Mark Hull has authored 141 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Infectious Diseases, 89 papers in Epidemiology and 37 papers in Hepatology. Recurrent topics in Mark Hull's work include HIV/AIDS Research and Interventions (82 papers), HIV, Drug Use, Sexual Risk (55 papers) and Hepatitis C virus research (37 papers). Mark Hull is often cited by papers focused on HIV/AIDS Research and Interventions (82 papers), HIV, Drug Use, Sexual Risk (55 papers) and Hepatitis C virus research (37 papers). Mark Hull collaborates with scholars based in Canada, United States and United Kingdom. Mark Hull's co-authors include Julio Montaner, Joan Montaner, Robert S. Hogg, Marina B. Klein, Curtis Cooper, Nathan J. Lachowsky, Viviane D. Lima, Zunyou Wu, Anthony W. Chow and Sharon Walmsley and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Mark Hull

130 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Hull Canada	25	1.3k	1.2k	537	316	264	141	2.2k
Catherine G. Sutcliffe United States	25	892 0.7×	925 0.8×	414 0.8×	249 0.8×	367 1.4×	98	1.9k
Nicolas Nagot France	31	2.2k 1.7×	1.3k 1.1×	304 0.6×	159 0.5×	566 2.1×	212	3.6k
Colm Bergin Ireland	26	1.1k 0.9×	1.4k 1.1×	641 1.2×	237 0.8×	228 0.9×	154	3.1k
Howard Libman United States	17	852 0.7×	1.1k 0.9×	193 0.4×	360 1.1×	324 1.2×	56	1.8k
Adeeba Kamarulzaman Malaysia	35	2.0k 1.6×	2.1k 1.7×	305 0.6×	186 0.6×	567 2.1×	142	3.7k
Neora Pick Canada	25	824 0.6×	1.4k 1.2×	249 0.5×	275 0.9×	153 0.6×	102	2.4k
Curt G. Beckwith United States	29	1.9k 1.5×	2.0k 1.6×	492 0.9×	145 0.5×	303 1.1×	113	3.3k
Grace Macalino United States	25	1.2k 0.9×	932 0.8×	251 0.5×	178 0.6×	229 0.9×	65	2.2k
Jack DeHovitz United States	33	1.8k 1.4×	2.5k 2.0×	188 0.4×	653 2.1×	569 2.2×	151	4.0k
Zara Shubber United Kingdom	25	1.1k 0.9×	1.7k 1.4×	109 0.2×	270 0.9×	519 2.0×	46	2.1k

Countries citing papers authored by Mark Hull

Since Specialization

Citations

This map shows the geographic impact of Mark Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hull more than expected).

Fields of papers citing papers by Mark Hull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hull. The network helps show where Mark Hull may publish in the future.

Co-authorship network of co-authors of Mark Hull

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hull. A scholar is included among the top collaborators of Mark Hull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hull. Mark Hull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grennan, Troy, Saira Mohammed, Joshua Edward, et al.. (2025). A Pilot, Randomized Controlled Trial of Dual Daily HIV and Sexually Transmitted Infection Pre-exposure Prophylaxis Using Tenofovir Disoproxil Fumarate/Emtricitabine and Doxycycline in Gay, Bisexual, and Other Men Who Have Sex With Men and Transgender Women: The DuDHS Study. Clinical Infectious Diseases. 5 indexed citations

Kooij, Katherine W., Katherine Heath, Taylor McLinden, et al.. (2025). Cohort Profile Update: Reflecting back and looking ahead: Updating the Comparative Outcomes and Service Utilization Trends (COAST) Study to include 28 years of linked data from people with and without HIV in British Columbia, Canada. International Journal for Population Data Science. 10(1). 2496–2496. 2 indexed citations

Sang, Jordan M., David Moore, Mark Hull, et al.. (2024). Impact of screening and doxycycline prevention on the syphilis epidemic among men who have sex with men in British Columbia: a mathematical modelling study. The Lancet Regional Health - Americas. 33. 100725–100725. 1 indexed citations

Oo, Myo Minn, et al.. (2024). HIV risk assessment tools for identifying individuals who could benefit from pre-exposure prophylaxis: a systematic review protocol. BMJ Open. 14(11). e090565–e090565.

Grace, Daniel, Mark Gaspar, Gordon Wells, et al.. (2023). Gay, bisexual, and queer men’s confidence in the Undetectable equals Untransmittable HIV prevention message: longitudinal qualitative analysis of the sexual decision-making of pre-exposure prophylaxis users over time. Sexual Health. 20(3). 223–231. 11 indexed citations

Toy, Junine, Katherine J. Lepik, David Moore, et al.. (2023). Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada. PLoS ONE. 18(3). e0283025–e0283025. 3 indexed citations

Wang, Lu, Michelle Y. Chen, Chris G. Richardson, et al.. (2023). Identifying Longitudinal CD4:CD8 Ratio Trajectories Indicative of Chronic Renal Disease Risk among People Living with HIV: An Application of Growth Mixture Models. Viruses. 15(2). 385–385. 1 indexed citations

Bouassa, Ralph‐Sydney Mboumba, Suzanne Samarani, Zabrina L. Brumme, et al.. (2023). SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses. 15(2). 575–575. 7 indexed citations

Grace, Daniel, Mark Gaspar, Gordon Wells, et al.. (2023). Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada. AIDS Patient Care and STDs. 37(6). 306–315. 10 indexed citations

10.

Moore, David, et al.. (2022). Links Between Childhood Abuse, Insidious Trauma, and Methamphetamine Use Across the Lifespan Among Gay, Bisexual, and Other Men Who Have Sex with Men: A Qualitative Analysis. Journal of Homosexuality. 70(13). 3192–3212. 10 indexed citations

11.

Armstrong, Heather L., Zishan Cui, Paul Sereda, et al.. (2022). Virological suppression among gay, bisexual, and other men who have sex with men living with HIV in Vancouver, Canada: A longitudinal cohort study from 2012–2017. PLoS ONE. 17(10). e0276596–e0276596. 1 indexed citations

12.

Hull, Mark, et al.. (2020). High Interest in Syphilis Pre-exposure and Post-exposure Prophylaxis Among Gay, Bisexual and Other Men Who Have Sex With Men in Vancouver and Toronto. Sexually Transmitted Diseases. 47(4). 224–231. 30 indexed citations

13.

Closson, Kalysha, Thomas L. Patterson, M. Ruth Lavergne, et al.. (2019). The syndemic effect of HIV/HCV co-infection and mental health disorders on acute care hospitalization rate among people living with HIV/AIDS: a population-based retrospective cohort study. Canadian Journal of Public Health. 110(6). 779–791. 7 indexed citations

14.

Eyawo, Oghenowede, Charles H. Goldsmith, Mark Hull, et al.. (2019). Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis. BMJ Open. 9(9). e025874–e025874. 54 indexed citations

15.

Kronfli, Nadine, Sahir Bhatnagar, Mark Hull, et al.. (2019). Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up. AIDS. 33(6). 1013–1022. 23 indexed citations

16.

Armstrong, Heather L., Zishan Cui, Paul Sereda, et al.. (2018). Trends in Awareness and Use of HIV PrEP Among Gay, Bisexual, and Other Men who have Sex with Men in Vancouver, Canada 2012–2016. AIDS and Behavior. 22(11). 3550–3565. 36 indexed citations

17.

Ma, Huiting, Oghenowede Eyawo, M. Ruth Lavergne, et al.. (2018). The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study. BMC Health Services Research. 18(1). 319–319. 2 indexed citations

18.

Eyawo, Oghenowede, Mark Hull, Kate Salters, et al.. (2018). Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada. BMJ Open. 8(1). e019115–e019115. 19 indexed citations

19.

Hogg, Robert S., Oghenowede Eyawo, Alexandra B. Collins, et al.. (2017). Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study. The Lancet HIV. 4(6). e270–e276. 52 indexed citations

20.

Hull, Mark, Zunyou Wu, & Julio Montaner. (2012). Optimizing the engagement of care cascade. Current Opinion in HIV and AIDS. 7(6). 579–586. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact